“You can think of this as a living medical device that is made from human cells that secrete insulin, along with an electronic life-support system." Reading time 3 minutes MIT scientists might be one ...
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion ...
The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, according to an industry press release. The implantable device (Portal ...
Using data from a nationally representative sample, investigators sought to determine trends in insulin device use. In the past 5 years, ambulatory insulin use among patients with type 2 diabetes (T2D ...
North America represents a leading share of the insulin delivery devices market, driven by a high prevalence of diabetes, strong adoption of advanced diabetes technologies, and well-established ...
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...
Share on Pinterest MIT engineers have developed a small implantable device that could help people with type 1 diabetes monitor their glucose levels. RichLegg/Getty Images Engineers at MIT say they ...
Insulin manufacturers are extending brand-name market exclusivity by filing multiple new patents on their products' delivery devices, a new analysis suggests. The data come from the publicly available ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results